Digital marketing

Your molecule can be protected through a combination of intellectual property (IP) strategies , depending on the stage of development and the specific characteristics of the pharmaceutical product. In pharmaceutical development, protection may involve patents covering the active pharmaceutical ingredient (API), new polymorphs or solid forms, compositions, formulations, manufacturing processes, or specific uses of the molecule. During preformulation development , studies can generate important information about the molecule’s physical, chemical, and stability characteristics. This information can help identify suitable solid forms, formulations, and development approaches that may support an appropriate intellectual property strategy. However, preformulation studies themselves do not automatically provide patent protection. The specific protection available for a molecule depends on factors such as novelty, inventive step, patentability, existing prior art, and the jurisdiction where pr...

Yes, preformulation development can be performed for generic pharmaceutical products to understand the properties and behavior of the drug substance before developing the final dosage form. Pharmaceutical preformulation studies help evaluate important drug characteristics such as solubility, pKa, particle size and distribution, polymorphism, hygroscopicity, thermal properties, stability, flow properties, and compatibility with commonly used excipients. At Molkem, pharmaceutical preformulation and formulation can be considered as connected stages of the development process. The information obtained during preformulation provides a scientific basis for formulation development, helping in the preparation and optimization of prototypes and supporting the development of a stable, consistent, and manufacturable generic pharmaceutical product.

Pharmaceutical preformulation and formulation are closely connected, but they are generally handled as separate yet integrated stages of pharmaceutical development. Pharmaceutical preformulation focuses on understanding the drug substance, including its physicochemical properties, solubility, stability, particle characteristics, and compatibility with potential excipients. The findings from these studies help guide the next stage of formulation development . During formulation development, the preformulation data is used to select suitable excipients, develop formulation prototypes, optimize the composition and manufacturing process, and evaluate the final product for quality, stability, and performance. At Molkem, preformulation development can therefore serve as the scientific foundation for formulation development, allowing both stages to work together as part of a coordinated pharmaceutical development programme.

Preformulation development is the initial stage of pharmaceutical product development where the physical, chemical, and biopharmaceutical properties of a drug substance are studied. Pharmaceutical preformulation helps understand important characteristics such as solubility, pKa, particle size, polymorphism, hygroscopicity, stability, flow properties, and compatibility with excipients. These studies help identify possible development challenges and provide the information needed to select a suitable dosage form and development approach. Formulation development uses the findings from preformulation studies to develop the final pharmaceutical product. It involves selecting suitable excipients, preparing and testing different formulation prototypes, optimizing the composition and manufacturing process, and evaluating the product for quality, stability, performance, and manufacturability. In simple terms, pharmaceutical preformulation focuses on understanding the drug and its properties...

No, every oral liquid is not automatically suitable for children. Pediatric medicines need to be developed with the child’s age, weight, dose requirements, and ability to take the medicine into consideration. An oral solution may be easier to administer than a tablet or capsule, but its ingredients, strength, and formulation still need to be appropriate for children. Factors such as taste, safety of excipients, dose accuracy, stability, and ease of administration are important when developing a pediatric liquid formulation . Therefore, the suitability of an oral formulation for children depends on its specific composition and intended age group, and it should be used according to the product information or healthcare professional’s advice.  

Oral solutions are liquid medicines designed to be taken by mouth, with the active pharmaceutical ingredient completely dissolved in a suitable liquid vehicle. They are used to deliver medicines when a liquid dosage form is preferred or when swallowing tablets or capsules may be difficult. Oral solutions can be formulated for a wide range of therapeutic purposes, including pain relief, allergy management, nutritional supplementation, gastrointestinal conditions, and other medical treatments. Because the active ingredient is already dissolved, oral solutions can provide a uniform dose when properly measured. Their formulation may also be designed to improve taste, stability, and ease of administration. The choice of an oral liquid depends on the drug’s properties, patient needs, and the requirements of the final oral formulation .